1.62
price up icon1.25%   0.02
after-market アフターアワーズ: 1.50 -0.12 -7.41%
loading

Evogene Ltd (EVGN) 最新ニュース

pulisher
Nov 23, 2024

Evogene Ltd. (NASDAQ:EVGN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 23, 2024
pulisher
Nov 22, 2024

Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities - Investing.com Canada

Nov 22, 2024
pulisher
Nov 22, 2024

Evogene Schedules Third Quarter 2024 Financial Results Release - GuruFocus.com

Nov 22, 2024
pulisher
Nov 21, 2024

Casterra Announces a Key Milestone in its Operational Expansion - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

Evogene Q3 2024 Earnings Preview - MSN

Nov 21, 2024
pulisher
Nov 21, 2024

Evogene Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 21, 2024
pulisher
Nov 21, 2024

Evogene earnings missed by $0.30, revenue fell short of estimates - Investing.com India

Nov 21, 2024
pulisher
Nov 21, 2024

Evogene Sees Revenue Growth and Expands AI Collaboration - TipRanks

Nov 21, 2024
pulisher
Nov 21, 2024

SEC Form 424B3 filed by Evogene Ltd - Quantisnow

Nov 21, 2024
pulisher
Nov 21, 2024

Evogene Reports Third Quarter 2024 Financial Results - PR Newswire

Nov 21, 2024
pulisher
Nov 19, 2024

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results - Marketscreener.com

Nov 19, 2024
pulisher
Nov 19, 2024

Finansavisen - Finansavisen

Nov 19, 2024
pulisher
Nov 15, 2024

Evogene stock hits 52-week low at $1.7 amid market challenges - Investing.com India

Nov 15, 2024
pulisher
Nov 13, 2024

Lavie Bio Announces Commercial Expansion of Yalos as Seed-Treatment for Soybean, Following Successful Field Trials - Krishak Jagat English

Nov 13, 2024
pulisher
Nov 12, 2024

Evogene subsidiary Lavie Bio announces commercial expansion of Yalos treatment - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials - WV News

Nov 12, 2024
pulisher
Nov 07, 2024

Evogene (EVGN) to Report Q3 2024 Results, Hosts Virtual Conference Call Nov 21 | EVGN Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 06, 2024

II: Exploring 🧭 TechBio - substack.com

Nov 06, 2024
pulisher
Nov 04, 2024

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design - Krishak Jagat English

Nov 04, 2024
pulisher
Nov 01, 2024

Evogene and Google Cloud Partner to Develop AI Foundation Model for Drug Discovery - HIT Consultant

Nov 01, 2024
pulisher
Nov 01, 2024

Evogene stock hits 52-week low at $2.13 amid market challenges - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

500: Something went wrong - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Evogene partners with Google Cloud for AI-driven molecule design By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

Evogene partners with Google Cloud for AI-driven molecule design - Investing.com India

Nov 01, 2024
pulisher
Oct 31, 2024

Biomica to Present at Digestive Disease Week (DDW) Conference 20 - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Evogene announces collaboration with Google Cloud - MSN

Oct 31, 2024
pulisher
Oct 30, 2024

Syngenta and Lavie Bio Announce Partnership to Discover and Deve - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya - Krishak Jagat English

Oct 30, 2024
pulisher
Oct 26, 2024

Evogene Ltd. (NASDAQ:EVGN) Sees Significant Growth in Short Interest - MarketBeat

Oct 26, 2024
pulisher
Oct 25, 2024

Evogene (NASDAQ:EVGN) Stock Crosses Below 200-Day Moving AverageShould You Sell? - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - MarketBeat

Oct 25, 2024
pulisher
Oct 18, 2024

Evogene stock hits 52-week low at $2.21 amid market challenges - Investing.com Nigeria

Oct 18, 2024
pulisher
Oct 17, 2024

Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Watershed, Evogene, and BGU to Expand Gene Editing Applications to White Leg Shrimp and Red Swamp Crayfish - ISAAA

Oct 16, 2024
pulisher
Oct 09, 2024

Evogene (NASDAQ:EVGN) Shares Pass Below Two Hundred Day Moving AverageHere's What Happened - MarketBeat

Oct 09, 2024
pulisher
Oct 09, 2024

Evogene (NASDAQ:EVGN) Research Coverage Started at StockNews.com - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology - PR Newswire

Oct 08, 2024
pulisher
Oct 03, 2024

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals - Krishak Jagat English

Oct 03, 2024
pulisher
Oct 02, 2024

Lavie Bio receives grant to advance ag-biologicals tech - World Bio Market Insights

Oct 02, 2024
pulisher
Oct 01, 2024

Evogene (NASDAQ:EVGN) Stock Price Crosses Below 200 Day Moving Average of $5.81 - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - MarketBeat

Oct 01, 2024
pulisher
Sep 30, 2024

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals - Lelezard

Sep 30, 2024
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
大文字化:     |  ボリューム (24 時間):